SCHEMBL7683159

SCHEMBL7683159

CCS(=O)(=O)N(C)c1cc(Cl)ccc1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.46
TSHR P16473 1/20 0.46
CASP1 P29466 1/20 0.46
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 3/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
TP53 P04637 1/20 0.42
RAB9A P51151 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
MYC P01106 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
ACLY P53396 2/20 0.40
POLB P06746 1/20 0.40
THRB P10828 1/20 0.40
RECQL P46063 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
GRIK1 P39086 3/20 0.39
FLT1 P17948 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7683236 0.85 MEN1 (0.44) SMN1; SMN2TSHRCASP1ALDH1A1KDM4E
SCHEMBL7556650 0.84 TSHR (0.49) SMN1; SMN2TSHRCASP1ALDH1A1KDM4E
SCHEMBL7685417 0.84 POLB (0.50) TSHRALDH1A1KDM4EKMT2AL3MBTL1
SCHEMBL7689766 0.81 SMN1; SMN2 (0.45) SMN1; SMN2TSHRCASP1ALDH1A1KDM4E
SCHEMBL7691842 0.79 C5AR1 (0.57) MEN1KMT2AACLYTDP1FLT1
SCHEMBL6643737 0.79 SMN1; SMN2 (0.57) SMN1; SMN2TSHRCASP1ALDH1A1KDM4E
SCHEMBL7552035 0.78 PSEN1 (0.45) SMN1; SMN2TSHRCASP1ALDH1A1KDM4E
SCHEMBL7691221 0.78 SLC6A9 (0.37) SMN1; SMN2TSHRALDH1A1KDM4EMEN1
SCHEMBL7556634 0.78 MCOLN3 (0.46) SMN1; SMN2TSHRCASP1ALDH1A1KDM4E
SCHEMBL24498149 0.78 TSHR (0.42) TSHRALDH1A1MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020045551-A1 4-benzoyl isoxazoles derivatives and their use as herbicides MUSIL TIBOR (GB) 2002-04-18 US disclosed
US-6323155-B1 EXCELLENT LEVEL OF HERBICIDAL ACTIVITY TOGETHER WITH CROP TOLERANCE RHONE-POULENC AGRICULTURE LIMITED (GB) 2001-11-27 US disclosed
EP-0674629-B1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE POULENC AGRICULTURE (GB) 1998-07-08 EP disclosed
EP-0674629-A1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE-POULENC AGRICULTURE LTD. (GB) 1995-10-04 EP disclosed
WO-1994014782-A1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE-POULENC AGRICULTURE LTD. (GB) 1994-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020045551-A1 4-benzoyl isoxazoles derivatives and their use as herbicides CBR3, CBR1, GLRA3 SMN1; SMN2 3433/4885TSHR 174/4885CASP1 2185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.